Neighbourly Pharmacy (TSX:NBLY) - Prezzo delle azioni, notizie e analisi

NBLY Panoramica delle azioni

Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. Maggiori dettagli

NBLY analisi fondamentale
Punteggio fiocco di neve
Valutazione	2/6
Crescita futura	1/6
Prestazioni passate	0/6
Salute finanziaria	3/6
Dividendi	0/6

Premi

Negoziato a 30.1% al di sotto della nostra stima del suo valore equo

Si prevede che i ricavi cresceranno 9.33% all'anno

Analisi del rischio

Importanti vendite da parte di insider negli ultimi 3 mesi

Neighbourly Pharmacy Inc. Concorrenti

CareRx

TSX:CRRX

CA$108.5m

North West

TSX:NWC

CA$2.5b

Sucro

TSXV:SUGR

CA$211.9m

Colabor Group

TSX:GCL

CA$102.0m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Neighbourly Pharmacy
Prezzi storici delle azioni
Prezzo attuale dell'azione	CA$18.54
Massimo di 52 settimane	CA$23.00
Minimo di 52 settimane	CA$12.05
Beta	0.29
1Variazione di 1 mese	0.93%
Variazione a 3 mesi	10.82%
Variazione di 1 anno	-13.36%
3Variazione a 3 anni	n/a
Variazione a 5 anni	n/a
Variazione dall'IPO	-17.56%

Notizie e aggiornamenti recenti

Recent updates

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Aug 15

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Mar 22

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Feb 17

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Dec 09

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

Aug 10

News Flash: Analysts Just Made A Substantial Upgrade To Their Neighbourly Pharmacy Inc. (TSE:NBLY) Forecasts

Mar 21

Is There An Opportunity With Neighbourly Pharmacy Inc.'s (TSE:NBLY) 48% Undervaluation?

Feb 27

Rendimenti per gli azionisti

	NBLY	CA Consumer Retailing	CA Mercato
7D	0.05%	-2.2%	0.7%
1Y	-13.4%	15.8%	21.7%

Ritorno vs Industria: NBLY ha avuto una performance inferiore rispetto al Canadian Consumer Retailing che ha registrato un rendimento 15.8 % nell'ultimo anno.

Rendimento vs Mercato: NBLY ha avuto una performance inferiore al mercato Canadian che ha registrato un rendimento 21.7 % nell'ultimo anno.

Volatilità dei prezzi

Is NBLY's price volatile compared to industry and market?
NBLY volatility
NBLY Average Weekly Movement	5.0%
Consumer Retailing Industry Average Movement	3.2%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.6%
10% least volatile stocks in CA Market	2.9%

Prezzo delle azioni stabile: NBLY non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 5% ) di NBLY è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
2015	3,648	Skip Bourdo	neighbourlypharmacy.ca

Neighbourly Pharmacy Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Neighbourly Pharmacy con la sua capitalizzazione di mercato?
NBLY statistiche fondamentali
Capitalizzazione di mercato	CA$840.40m
Guadagni(TTM)	-CA$32.70m
Ricavi(TTM)	CA$874.61m

1.0x

Rapporto P/S

-25.6x

Rapporto P/E

NBLY è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
NBLY Conto economico (TTM)
Ricavi	CA$874.61m
Costo del fatturato	CA$527.56m
Profitto lordo	CA$347.05m
Altre spese	CA$379.76m
Guadagni	-CA$32.70m

Ultimi guadagni dichiarati

Dec 30, 2023

Prossima data di guadagno

n/a

Utile per azione (EPS)	-0.72
Margine lordo	39.68%
Margine di profitto netto	-3.74%
Rapporto debito/patrimonio netto	44.5%

Come si è comportato NBLY nel lungo periodo?

Vedi performance storica e confronto

NBLY Panoramica delle azioni

Premi

Analisi del rischio

Neighbourly Pharmacy Inc. Concorrenti

TSX:CRRX

CA$108.5m

TSX:NWC

CA$2.5b

TSXV:SUGR

CA$211.9m

TSX:GCL

CA$102.0m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Neighbourly Pharmacy Inc. Announces CFO Changes

Neighbourly Pharmacy Inc. COM to Be Deleted from OTC Equity

Neighbourly Closes Go-Private Deal with Persistence

Third quarter 2024 earnings released: CA$0.11 loss per share (vs CA$0.20 loss in 3Q 2023)

Price target decreased by 12% to CA$18.80

Neighbourly Pharmacy Inc. Announces Executive Changes

Recent updates

Neighbourly Pharmacy Inc. Announces CFO Changes

Neighbourly Pharmacy Inc. COM to Be Deleted from OTC Equity

Neighbourly Closes Go-Private Deal with Persistence

Third quarter 2024 earnings released: CA$0.11 loss per share (vs CA$0.20 loss in 3Q 2023)

Price target decreased by 12% to CA$18.80

Neighbourly Pharmacy Inc. Announces Executive Changes

Neighbourly Pharmacy Inc. to Report Q3, 2024 Results on Feb 13, 2024

Upcoming dividend of CA$0.045 per share at 1.0% yield

Now 22% undervalued

Neighbourly Pharmacy Inc. to Report Q2, 2024 Results on Oct 24, 2023

PCP GP, L.P. entered into a letter of intent to acquire remaining all unknown minority stake in Neighbourly Pharmacy Inc. (TSX:NBLY) for CAD 470 million.

New major risk - Share price stability

Upcoming dividend of CA$0.045 per share at 1.1% yield

Neighbourly Pharmacy (TSE:NBLY) Will Pay A Dividend Of CA$0.045

Forecast breakeven date pushed back to 2025

First quarter 2024 earnings released: CA$0.27 loss per share (vs CA$0.029 loss in 1Q 2023)

Neighbourly Pharmacy Inc. to Report Q1, 2024 Results on Aug 01, 2023

Upcoming dividend of CA$0.045 per share at 1.1% yield

Independent Chairman of the Board recently bought CA$599k worth of stock

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 3, 2023

Full year 2023 earnings released: CA$0.37 loss per share (vs CA$2.57 loss in FY 2022)

Neighbourly Pharmacy Inc. (TSX:NBLY) entered into a binding agreement to acquire Seven Pharmacies in Western Canada.

Neighbourly Pharmacy Inc. (TSX:NBLY) has entered into a binding agreement to acquire Three pharmacies in Ontario.

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 01, 2023

Neighbourly Pharmacy Inc. to Report Q4, 2023 Results on Jun 08, 2023

Estimating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

Upcoming dividend of CA$0.045 per share at 0.7% yield

CEO & Director recently bought CA$272k worth of stock

Forecast breakeven date pushed back to 2024

Results: Neighbourly Pharmacy Inc. Delivered A Surprise Loss And Now Analysts Have New Forecasts

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on April 11, 2023

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Consensus EPS estimates fall by 42%

Neighbourly Pharmacy Inc. to Report Q3, 2023 Results on Feb 14, 2023

Neighbourly Pharmacy Inc. Announces CEO Changes

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Cloverdale Pharmacy Ltd. and Steveston Health Centre Ltd. from CloudMD Software & Services Inc. (TSXV:DOC)

Calculating The Fair Value Of Neighbourly Pharmacy Inc. (TSE:NBLY)

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on December 20, 2022

Consensus forecasts updated

Neighbourly Pharmacy Inc. (TSX:NBLY) acquired Assets of a Retail Pharmacy Located in Manitoba.

Neighbourly Pharmacy Inc. (TSX:NBLY) enter into a binding agreement to acquire Two Community Pharmacies Located in British Columbia.

Consensus forecasts updated

Now 21% undervalued after recent price drop

Neighbourly Pharmacy Inc. Appoints Billy Wong as CFO to Succeed Terri Smyth

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy's (TSE:NBLY) Robust Earnings Are Supported By Other Strong Factors

First quarter 2023 earnings: EPS misses analyst expectations

Neighbourly Pharmacy Inc. Declares Dividend on Common Share for the First Quarter Ended June 18, 2022, Payable on September 27, 2022

Upcoming dividend of CA$0.045 per share

Neighbourly Pharmacy Inc. (TSX:NBLY) completed the acquisition of Rubicon Pharmacies Canada Inc.

Full year 2022 earnings: EPS misses analyst expectations

Price target decreased to CA$33.44

Neighbourly Pharmacy Inc. Announces Quarterly Dividend, Payable on August 18, 2022

Neighbourly Pharmacy Inc. to Report Q1, 2023 Results on Aug 02, 2022

Neighbourly Pharmacy Inc., Annual General Meeting, Aug 02, 2022

Neighbourly Pharmacy Inc. to Report Q4, 2022 Results on Jun 23, 2022

High number of new and inexperienced directors

Neighbourly Pharmacy Inc. announced that it has received CAD 138.163875 million in funding from PCP GP, L.P.